ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc (NASDAQ-“BRLI”) announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the Lazard Capital Markets 8th Annual Healthcare Conference on Wednesday, November 16, 2011, at The Pierre Hotel located in New York, NY. The BioReference Laboratories presentation is scheduled to begin at 1:00 p.m. Eastern Standard Time.
Those wishing to listen to the live audio webcast may access it on the Company’s corporate web site, www.bioreference.com. Please go to the site ten minutes before the presentation is ready to begin. You will need to register as well as download and install any necessary audio software. The webcast will be archived on the BioReference website for 30 days following the call.
About BioReference Laboratories, Inc.
BRLI is the fourth largest full service laboratory in the United States and the largest independent regional laboratory in the Northeastern market, primarily a clinical testing laboratory servicing physician offices with concentrations in the focused markets of esoteric testing, molecular diagnostics, anatomical pathology, women's health and correctional health care. BRLI operates as a national oncology laboratory as GenPath. Better science, superior technology and better service have enabled GenPath to earn a reputation as one of the premier hematopathology laboratories in the country. BRLI's innovative technology platform for sexually transmitted infections has enabled it to expand as a national laboratory in the area of Women's Health. GeneDx, a wholly owned subsidiary, is the BRLI genetics laboratory and is typically recognized as the leading laboratory for testing of rare genetic diseases; GeneDx has now become a technology leader with GenomeDx, based on a CGH array platform and its NextGen sequence offerings that are currently offered in cardiology and will be offered in the future in other disease specific areas.